Produktsname: | QUINIDINE SULFATE (2:1) (salt) |
CAS Registry Number: | 50-54-4 |
EINECS: | 200-046-3 |
Synonyme: | Cinchonan-9-ol, 6-methoxy-, (9S)-, sulfate (2:1) (salt);Kinichron;Chinidine sulfate;Quinidine sulfate (salt);Quinidine monosulfate;Quinidine, sulfate (2:1) (salt);Systodin;Quinidine bisulfate;(S)-[(4S,5S,7R)-5-ethenyl-1-azabicyclo[2.2.2]oct-7-yl]-(6-methoxyquinolin-4-yl)methanol;Quinidine sulfate anhydrous;Quinidate;Cin quin;Quinicardine; sulfuric acid;Quinitex;SK-Quinidine sulfate;Auriquin;Cinchonan-9-ol,6'-methoxy-,(9S)-,sulfate (2:1) (salt);Vanquin;Quinidex;QUINIDINE;Cin-Quin;QUINIDINE SULFATE (2:1) (salt);QUINIDINE SULPHATE;Quinidine sulfate;Quinora;CINCHONAN-9-OL, 6′-METHOXY-, (9S)-, SULFATE (2:1) (SALT) (9CI);(9S)-6′-METHOXYCINCHONAN-9-OL SULFATE (2:1) (SALT); |
Molecular Structure: | |
Molecular Formula: | C40H50N4O8S |
Molecular Weight: | 746.91 |
Dichte: | g/cm3 |
Boiling Point: | 495.9°Cat760mmHg |
Schmelzpunkt: | 212°C |
Flash Point: | 253.7°C |
Risiko-Codes: | 22 |
S-Sätze: | Poison by intraperitoneal and intravenous routes. Moderately toxic by ingestion and subcutaneous routes. Human systemic effects: arrythmias, cholestatic conjunctive irritation, cyanosis, death, distorted perceptions, dyspnea, fever, hallucinations, hepatitis, increased body temperature, irritative dermatitis, jaundice, joints effects, liver function impairment, other vascular and pulmonary changes, somnolence, transaminases changes, tremors, tumors. When heated to decomposition it emits very toxic fumes of NOx and SOx. See also QUINIDINE. |